Hydrocortisone BE studies for UK [Design Issues]

posted by HallaGulla – United Kingdom, 2022-05-16 19:37 (201 d 12:42 ago) – Posting: # 22992
Views: 652

Dear All

It would be great if someone can put some light on dose linearity for Hydrocortisone acetate. The information available in the literature is very confusing with few suggesting it's linear between the dose up to 40mg and then few say nonlinear due to absorption and protein binding and show less than dose-proportional increase in AUC.


In case we have to plan this study for the EU/UK do we need to do a study on higher and lower strength both?

Cheers
HG

Complete thread:

UA Flag
Activity
 Admin contact
22,427 posts in 4,694 threads, 1,598 registered users;
18 visitors (0 registered, 18 guests [including 11 identified bots]).
Forum time: 07:20 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5